Literature DB >> 17597069

Binding of ADAM28 to P-selectin glycoprotein ligand-1 enhances P-selectin-mediated leukocyte adhesion to endothelial cells.

Masayuki Shimoda1, Gakuji Hashimoto, Satsuki Mochizuki, Eiji Ikeda, Norihiro Nagai, Susumu Ishida, Yasunori Okada.   

Abstract

ADAMs (a disintegrin and metalloproteinases) are a recently discovered gene family of multifunctional proteins with the disintegrin-like and metalloproteinase domains. To analyze the biological functions of ADAM28, we screened binding molecules to secreted-type ADAM28 (ADAM28s) by the yeast two-hybrid system and identified P-selectin glycoprotein ligand-1 (PSGL-1). Binding between the disintegrin-like domain of ADAM28s and the extracellular portion of PSGL-1 was determined by yeast two-hybrid assays, binding assays of the domain-specific recombinant ADAM28s species using PSGL-1 stable transfectants and leukocyte cell lines expressing native PSGL-1 (HL-60 cells and Jurkat cells), and co-immunolocalization and co-immunoprecipitation of the molecules in these cells. Incubation of HL-60 cells with recombinant ADAM28s enhanced the binding to P-selectin-coated wells and P-selectin-expressing endothelial cells. In addition, intravenous injection of ADAM28s-treated HL-60 cells increased their accumulation in the pulmonary microcirculation and alveolar spaces in a mouse model of endotoxin-induced inflammation. These data suggest a novel function that ADAM28s promotes PSGL-1/P-selectin-mediated leukocyte rolling adhesion to endothelial cells and subsequent infiltration into tissue spaces through interaction with PSGL-1 on leukocytes under inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597069     DOI: 10.1074/jbc.M702414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 2.  Metalloproteinases and their inhibitors: regulators of wound healing.

Authors:  Sean E Gill; William C Parks
Journal:  Int J Biochem Cell Biol       Date:  2007-10-26       Impact factor: 5.085

3.  Role of ADAMs in endothelial cell permeability: cadherin shedding and leukocyte rolling.

Authors:  Bharathy Ponnuchamy; Raouf A Khalil
Journal:  Circ Res       Date:  2008-05-23       Impact factor: 17.367

Review 4.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

5.  Multiple non-catalytic ADAMs are novel integrin α4 ligands.

Authors:  Lei Wang; Jason A Hoggard; Erica D Korleski; Gideon V Long; Brandy C Ree; Kenneth Hensley; Stephen R Bond; Tyra G Wolfsberg; JianMing Chen; Tonya N Zeczycki; Lance C Bridges
Journal:  Mol Cell Biochem       Date:  2017-09-14       Impact factor: 3.396

6.  ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α.

Authors:  Jeremy B M Jowett; Yasunori Okada; Peter J Leedman; Joanne E Curran; Matthew P Johnson; Eric K Moses; Harald H H Goring; Satsuki Mochizuki; John Blangero; Leah Stone; Holly Allen; Chris Mitchell; Vance B Matthews
Journal:  Immunol Cell Biol       Date:  2012-09-25       Impact factor: 5.126

7.  Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.

Authors:  Yan-ling Lv; Dong-mei Yuan; Qing-bo Wang; Ping Zhan; Liang Luo; Tang-feng Lv; Hong-bing Liu; Yu-feng Li; Jian Wen; Yong Song
Journal:  Med Oncol       Date:  2012-02-22       Impact factor: 3.064

8.  Identification of genes expressed in the migrating primitive myeloid lineage of Xenopus laevis.

Authors:  Zachary N Agricola; Amrita K Jagpal; Andrew W Allbee; Allison R Prewitt; Emily T Shifley; Scott A Rankin; Aaron M Zorn; Alan P Kenny
Journal:  Dev Dyn       Date:  2015-11-20       Impact factor: 3.780

Review 9.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

10.  Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.

Authors:  Masayuki Shimoda; Keisuke Horiuchi; Aya Sasaki; Tetsuya Tsukamoto; Koji Okabayashi; Hirotoshi Hasegawa; Yuko Kitagawa; Yasunori Okada
Journal:  EBioMedicine       Date:  2016-02-09       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.